drugset / Trial / NCT04682288

Levofloxacin Ocular Implant for Ocular Surgery

NCT04682288

Phase 1 Completed 5 enrolled PolyActiva Pty Ltd
NaSingle-groupOpen-labelTreatment

Summary

This is a multi center, open label, interventional study in one eye of 5 subjects scheduled for uncomplicated cataract surgery with administration of a single Levofloxacin Ocular Implant in the posterior sulcus of the surgical eye at the end of cataract surgery.

Timeline

Start
2021-01-04
Primary completion
2021-10-14
Completion
2021-10-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Levofloxacin Small molecule Other

Indications